Article
Refine
Year of publication
Institute
- Fachbereich Medizintechnik und Technomathematik (1591)
- Fachbereich Wirtschaftswissenschaften (705)
- Fachbereich Elektrotechnik und Informationstechnik (638)
- Fachbereich Energietechnik (609)
- Fachbereich Chemie und Biotechnologie (602)
- INB - Institut für Nano- und Biotechnologien (542)
- Fachbereich Maschinenbau und Mechatronik (484)
- IfB - Institut für Bioengineering (449)
- Fachbereich Luft- und Raumfahrttechnik (379)
- Fachbereich Bauingenieurwesen (333)
- Solar-Institut Jülich (107)
- Fachbereich Architektur (79)
- Fachbereich Gestaltung (58)
- ECSM European Center for Sustainable Mobility (43)
- ZHQ - Bereich Hochschuldidaktik und Evaluation (42)
- Nowum-Energy (36)
- Sonstiges (23)
- Institut fuer Angewandte Polymerchemie (20)
- Freshman Institute (18)
- MASKOR Institut für Mobile Autonome Systeme und Kognitive Robotik (16)
- IBB - Institut für Baustoffe und Baukonstruktionen (10)
- Arbeitsstelle fuer Hochschuldidaktik und Studienberatung (3)
- IMP - Institut für Mikrowellen- und Plasmatechnik (3)
- Verwaltung (3)
- FH Aachen (2)
- Kommission für Forschung und Entwicklung (1)
- Kommission für Planung und Finanzen (1)
Language
Document Type
- Article (5644) (remove)
Keywords
- Einspielen <Werkstoff> (7)
- Multimediamarkt (6)
- Rapid prototyping (5)
- avalanche (5)
- Earthquake (4)
- FEM (4)
- Finite-Elemente-Methode (4)
- LAPS (4)
- Rapid Prototyping (4)
- biosensors (4)
Chelate stabilization of a titanium(IV)–salan alkoxide by ligand exchange with 2,6-pyridinedicarboxylic acid (dipic) resulted in heptacoordinate complex 3 which is not redox-active, stable on silica gel and has increased aqueous stability. 3 is highly toxic in HeLa S3 and Hep G2 and has enhanced antitumor efficacy in a mouse cervical-cancer model.
Persistent infection with high-risk human papillomaviruses (hrHPV) can result in the formation of anogenital cancers. As hrHPV proteins E6 and E7 are required for cancer initiation and maintenance, they are ideal targets for immunotherapeutic interventions. Previously, we have described the development of DNA vaccines for the induction of HPV16 E6 and E7 specific T cell immunity. These vaccines consist of ‘gene-shuffled’ (SH) versions of HPV16 E6 and E7 that were fused to Tetanus Toxin Fragment C domain 1 (TTFC) and were named TTFC-E6SH and TTFC-E7SH. Gene-shuffling was performed to avoid the risk of inducing malignant transformation at the vaccination site. Here, we describe the preclinical safety evaluation of these candidate vaccines by analysis of their transforming capacity in vitro using established murine fibroblasts (NIH 3T3 cells) and primary human foreskin keratinocytes (HFKs). We demonstrate that neither ectopic expression of TTFC-E6SH and TTFC-E7SH alone or in combination enabled NIH 3T3 cells to form colonies in soft agar. In contrast, expression of HPV16 E6WT and E7WT alone or in combination resulted in effective transformation. Similarly, retroviral transduction of HFKs from three independent donors with both TTFC-E6SH and TTFC-E7SH alone or in combination did not show any signs of immortalization. In contrast, the combined expression of E6WT and E7WT induced immortalization in HFKs from all donors. Based on these results we consider it justified to proceed to clinical evaluation of DNA vaccines encoding TTFC-E6SH and TTFC-E7SH in patients with HPV16 associated (pre)malignancies.
Efficient FACS selection procedure for cells undergoing Flp-mediated site-specific conversions
(1998)
Transcription-promoting genomic sites in mammalia: their elucidation and architectural principles
(1998)
The transgeneticist's toolbox: novel methods for the targeted modification of eukaryotic genomes
(2000)